MaSSSoftech

And Hires Search Firm to Fill President/COO and CIO Positions
BATON ROUGE, La.--(Business Wire)--
Amedisys, Inc. (NASDAQ: AMED)(or the "Company"), one of America's leading home
health and hospice nursing companies, today announced the appointment of Dr.
Michael O. Fleming as the Chief Medical Officer. He is past President of the
American Academy of Family Physicians (AAFP) and the Louisiana Academy of Family
Physicians, and is founding Chairman of the Louisiana Health Care Quality Forum,
a partnership with the State of Louisiana aiming to provide high-quality health
care to the state. Dr. Fleming has served as Speaker of the Congress of
Delegates of the AAFP and as Board Chair of the AAFP Board of Directors. As an
active member of the medical quality field, he serves on various boards and
panels to the health information technology industry. In this role as Chief
Medical Officer, Dr. Fleming will lead all of our clinical quality initiatives
and take an active role in shaping our future strategies.

The Company is pleased to announce that Tasha Mears, Senior Vice President of
Clinical Operations has been appointed by the Centers for Medicare and Medicaid
Services (CMS) as a member of the Technical Expert Panel Project: Care
Transition Measure Development. This prestigious panel has been formed to
develop measures used to deliver quality care to Medicare beneficiaries. Ms.
Mears is one of a select clinical few nationwide who were chosen to this panel.
She is a Registered Nurse, and has served at Amedisys in a number of field
positions including Clinical Director, Regional Administrator, Regional Director
of Business Development and Director of Episode Management. She also served as
Director of Quality and Clinical Technology and as Vice President of Quality
Management and Analytics prior to her current role. Ms. Mears has also
contributed to several studies related to Medicare spending and hospitalization
and has participated on numerous industry related quality improvement projects
and panels. She will report directly to Dr. Fleming.

The Company also announced that it has engaged Russell Reynolds Associates to
conduct searches to fill the positions of President/Chief Operating Officer and
that of Chief Information Officer. The searches will be national in scope and
will include both internal and external candidates.

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock
trades on the NASDAQ Global Select Market under the symbol "AMED".

This press release includes statements that may constitute "forward-looking"
statements, usually containing the words "believe", "estimate", "project",
"expect", "anticipate" or similar expressions.Forward-looking statements
inherently involve risks and uncertainties that could cause actual results to
differ materially from the forward-looking statements.Many of the factors that
could cause or contribute to such differences are described in the Company`s
periodic reports and registrations statements filed with the Securities and
Exchange Commission, and include, but are not limited to the following: general
economic and business conditions, changes in or failure to comply with existing
regulations or the inability to comply with new government regulations on a
timely basis, changes in Medicare and other medical reimbursement levels,
ability to complete acquisitions announced from time to time, and any financing
related thereto, the ability to meet debt service requirements and to comply
with covenants in debt agreements, adverse changes in federal and state laws
relating to the health care industry, demographic changes, availability and
terms of capital, ability to attract and retain qualified personnel, ongoing
development and success of new start-ups, ability to successfully integrate
newly acquired agencies, changes in estimates and judgments associated with
critical accounting policies, business disruption due to natural disasters or
acts of terrorism, and various other matters, many of which are beyond
management`s control. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this release.

Our company website address is www.amedisys.com. We use our website as a channel
of distribution for important company information. Important information,
including press releases, analyst presentations and financial information
regarding the Company is routinely posted on and accessible on the "Investor
Relations" subpage of our website, which is accessible by clicking on the tab
labeled "Investors" on our website home page.We will also use our website to
expedite public access to time-critical information regarding the Company in
advance of or in lieu of distributing a press release or a filing with the
Securities and Exchange Commission ("SEC") disclosing the same information.In
addition, we make available on the Investor Relations subpage of our website
(under the link "SEC filings") free of charge our annual reports on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K, ownership reports
on Forms 3, 4 and 5 and any amendments to those reports as soon as practicable
after we electronically file such reports with the SEC. Further, copies of our
Certificate of Incorporation and Bylaws, our Code of Ethical Business Conduct
and the charters for the Audit, Compensation and Nominating and Governance
Committees of our Board are also available on the Investor Relations subpage of
our website (under the link "Corporate Governance").

Additional information on the Company can be found at:

www.amedisys.com